Inhibition of Survivin Restores the Sensitivity of Breast Cancer Cells to Docetaxel and Vinblastine
-
Published:2014-08-03
Issue:2
Volume:174
Page:667-681
-
ISSN:0273-2289
-
Container-title:Applied Biochemistry and Biotechnology
-
language:en
-
Short-container-title:Appl Biochem Biotechnol
Author:
Ghanbari Parisa,Mohseni Mahsa,Tabasinezhad Maryam,Yousefi Bahman,Saei Amir Ata,Sharifi Simin,Rashidi Mohammad Reza,Samadi Nasser
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference65 articles.
1. Siegel, R., Naishadham, D., & Jemal, A. (2013). CA: A Cancer Journal for Clinicians, 63(1), 11–30. 2. Crown, J., Dieras, V., Kaufmann, M., von Minckwitz, G., Kaye, S., Leonard, R., Marty, M., Misset, J. L., Osterwalder, B., & Piccart, M. (2002). Lancet Oncology, 3, 719–727. 3. Lee, E. A., Keutmann, M. K., Dowling, M. L., Harris, E., Chan, G., & Kao, G. D. (2004). Molecular Cancer Therapeutics, 3, 661–669. 4. Petrylak, D. P. (2000). Seminars in Oncology, 27, 24–29. 5. Shepherd, F. A., Fossella, F. V., Lynch, T., Armand, J. P., Rigas, J. R., & Kris, M. G. (2001). Seminars in Oncology, 28, 4–9.
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|